With lung cancer affecting the lives of so many people, it’s important to understand the disease and what we can do to improve our chances of beating it....
NFCR Leads Delegation to Chinese BioMed Conference, Signs MOU with Host
The National Foundation for Cancer Research, led by Chairman Joseph F. Franlin and President Sujuan Ba, recruited a delegation of eight U.S. cancer technology start-ups for a successful exploratory mission to China. The companies—ArrayBio, Eutropics, Immix Biopharma, InterLeukin Therapeutics, International Cancer Impact Fund, InVaMet Therapeutics, Nonpareil Biotechnologies and Stromatis Pharma—were…...
In the Pink: Preventing Breast Cancer in Every Season of Life
As the tidal wave of pink paraphernalia synonymous with October ebbs, and our thoughts turn to turkey, football and autumn foliage in full Technicolor array; it’s important to keep in mind that preventing breast cancer is a year-round affair. Vigilance is mandatory; that is if preventing and detecting the onset…...
Outrunning Cancer: Exercise is the Best “Medicine”
Many common cancer treatments and surgeries are invasive and have uncomfortable or painful side-effects which make movement and participation in even the most basic of activities a challenge. Patients are traditionally told to take it easy after being diagnosed or undergoing surgery and treatments. However, a change in school of…...
Genetic Marker Can Help Focus Prostate Cancer Therapies
CLEVELAND, OH — Two studies conducted by the Cleveland Clinic revealed how a testosterone-related genetic abnormality can help predict individual patient responses to specific prostate cancer therapies. The studies, published in the October 12 issue of JAMA Oncology, suggest that men who inherit this variant would benefit from a personalized…...
Firefighters: Heroes in the Line of Fire
All consuming, unforgiving, destructive: adjectives easily attributable to the symptoms, treatments, diagnosis and battle with cancer. These descriptors also paint an accurate rendering of the infernos into which American fire fighters, America’s Bravest, venture unflinchingly as they perform their duty. In a recent exposé, experts uncovered a disturbing trend which…...
Novel CAR-T Treatment Approved for Second Indication
In the past two months, the FDA has approved a revolutionary new form of immunotherapy, called chimeric antigen receptor (CAR) T cell therapy, for two blood cancers: B cell acute lymphoblastic leukemia (ALL) in August, 2017 and now on October 18th, for aggressive diffuse large B cell lymphoma (DLBCL), a…...
NFCR President and COO to co-organize and speak at SNOChina 2018
The Society for Neuro-Oncology of China has invited Dr. Sujuan Ba, the president and chief operating officer of the National Foundation for Cancer Research (NFCR), to give a lecture at its annual meeting, SNOChina 2018, to be held in Changsha, Hunan on March 16-17, 2018. The Society will present the…...
Strategic Media Partner
